GlassScriptPhysician profile
Stephen Thomas Broughton
NPI 1215314877
$33,553.95
in general payments reported to CMS, 2019-2025
19 companies · $1,356 in 2025
The $1,356 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $697 · 2022: $23K · 2023: $7,724 · 2024: $698 · 2025: $1,356.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $4,863 · Food and Beverage: $4,722 · Education: $192.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $4,863.45 |
| Food and Beverage | $4,721.79 |
| Education | $192.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $12,744.51 | 2022-2024 | Mitraclip, Navitor, Portico |
| Medtronic, INC. | $11,347.88 | 2022-2025 | Corevalve Evolut R |
| Edwards Lifesciences Corporation | $4,550.97 | 2022-2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv), Edwards Sapien 3 Ultra Transcatheter Heart Valve, Pascal |
| Boston Scientific Corporation | $2,029.31 | 2021-2022 | |
| W. L. Gore & Associates, INC. | $1,408.56 | 2023 | Gore Cardioform Septal Occluder |
| Shockwave Medical, INC | $464.62 | 2022-2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Cardiovascular Systems INC. | $337.41 | 2021-2023 | Diamondback Coronary |
| Inari Medical, INC. | $268.14 | 2023-2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Abiomed | $161.76 | 2024-2025 | Impella |
| Lexicon Pharmaceuticals, INC. | $49.25 | 2024 | |
| Terumo Medical Corporation | $38.21 | 2022 | |
| Novartis Pharmaceuticals Corporation | $35.57 | 2023-2025 | |
| E.R. Squibb & Sons, L.L.C. | $18.90 | 2024 | Cobenfy |
| Angiodynamics, INC. | $18.57 | 2025 | Alphavac |
| Cardiva Medical, INC. | $17.43 | 2022 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $17.30 | 2024 | Winrevair |
| United Therapeutics Corporation | $16.20 | 2025 | Tyvaso |
| Vanda Pharmaceuticals INC. | $15.57 | 2025 | Fanapt, Hetlioz |
| Astrazeneca Pharmaceuticals LP | $13.79 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephen Broughton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.